Selective Precision Targeting (SPoT)
Department of Health and Human Services ▸ National Institutes of Health
Description
The National Center for Advancing Translational Science (NCATS) is launching the Selective Precision Targeting (SPoT) initiative to improve precise drug delivery to hard-to-reach body areas like the blood-brain barrier and tumors. The initiative aims to enhance nanoparticle therapeutics targeting, assess drug distribution and side effects using multi-organ systems, demonstrate drug functionality, and find the best administration routes. The initiative is supported by the Cures Acceleration N…
The National Center for Advancing Translational Science (NCATS) seeks to advance its mission by establishing a new initiative called Selective Precision Targeting (SPoT) to determine a mechanism for precise and on-target therapeutic drug delivery to specific hard-to-reach locations within the hu…
Source
Grant ID
FOR-TR-27-003
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Small businesses
- County governments
- Independent school districts
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Native American tribal governments (Federally recognized)
- Public and State controlled institutions of higher education
- State governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- For profit organizations other than small businesses
- Public housing authorities/Indian housing authorities
Awards & Funding
Total Funding
$1.5M
Funding Amount
Discretionary
Links
Similar opportunities
- Toward Translation of Cancer Nanotechnology Interventions (TTNCI)
- Development and Validation of Animal Models and Ex Vivo Systems for Neurological and Neuromuscular Disorders
- Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
- NIAID Investigator Initiated Program Project Applications
- Innovative Research in Cancer Nanotechnology (IRCN)